======= DACT2 =======
== Gene Information ==
* **Official Symbol**: DACT2
* **Official Name**: dishevelled binding antagonist of beta catenin 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=168002|168002]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q5SW24|Q5SW24]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=DACT2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DACT2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/608966|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Involved in regulation of intracellular signaling pathways during development. Negatively regulates the Nodal signaling pathway, possibly by promoting the lysosomal degradation of Nodal receptors, such as TGFBR1. May be involved in control of the morphogenetic behavior of kidney ureteric bud cells by keeping cells epithelial and restraining their mesenchymal character. May play an inhibitory role in the re-epithelialization of skin wounds by attenuating TGF-beta signaling (By similarity). {ECO:0000250}.
No Pfam Domain information is available for this gene.
|negative regulation of nodal signaling pathway|
|inner medullary collecting duct development|
|delta-catenin binding|
|regulation of nodal signaling pathway|
|negative regulation of activin receptor signaling pathway|
|collecting duct development|
|protein kinase A binding|
|regulation of activin receptor signaling pathway|
|epithelial cell morphogenesis|
|protein kinase C binding|
|beta-catenin binding|
|hematopoietic progenitor cell differentiation|
|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|
|epithelial cell development|
|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|
|kidney development|
|negative regulation of cell adhesion|
|renal system development|
|urogenital system development|
|transcription factor binding|
|regulation of Wnt signaling pathway|
|skin development|
|cell morphogenesis involved in differentiation|
|hemopoiesis|
|hematopoietic or lymphoid organ development|
|immune system development|
|epithelial cell differentiation|
|regulation of cell adhesion|
|cell morphogenesis|
|cellular component morphogenesis|
|tube development|
|epithelium development|
|negative regulation of signal transduction|
|negative regulation of cell communication|
|negative regulation of signaling|
|negative regulation of response to stimulus|
|cell development|
|tissue development|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5233
* **Expression level (log2 read counts)**: -7.68
{{:chemogenomics:nalm6 dist.png?nolink |}}